Massive pulmonary embolism as the first manifestation in a patient with double heterozygocity for MTHFR and prothrombin 20210 G/A Source: Eur Respir J 2003; 22: Suppl. 45, 443s Year: 2003
Occurrence and clinical significance of hOGG1 Ser326Cys polymorphism in NSCLC patients from northern Poland Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006
Occurrence and clinical significance of hOGG1 Ser326Cys polymorphism in NSCLC patients from northern Poland Source: Eur Respir J 2007; 30: Suppl. 51, 130s Year: 2007
Prothrombin 20210 G/A mutation and EPCR I/D polymorphisms were rare in patients with pulmonary thromboembolism in Chinese Han population Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
MTHFR gene polymorphism in nonsmall cell lung cancer Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development Source: Eur Respir J 2007; 30: Suppl. 51, 131s Year: 2007
Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005
Predictive role of MMP-2 genetic variants on severe hematologic toxicity of NSCLC patients treated with first-line, platinum-based chemotherapy Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
ACE gene I/D polymorphism in sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: from the bench to the bedside Year: 2010
ACE gene I/D polymorphism and initial disease presentation in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 75s Year: 2003
TP 53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) developmentSource: Annual Congress 2006 - Molecular pathology and genetics of lung cancer Year: 2006
Occurence and clinical significance of MDM2 309T/G polymorphism in NSCLC patients from Northern Poland Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
ERCC1 and MDR1 expression and polymorphism frequency related to clinical outcome and chemotherapy response in a Brazilian sample of NSCLC patients Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013
TNF-α polymorphism as a prognostic marker for MTX efficacy in progressive pulmonary sarcoidosis Source: International Congress 2016 – Sarcoidosis Year: 2016
MTHFR 677C>T polymorphism in patients with COPD Source: International Congress 2015 – Promising novel findings in translational pulmonary research Year: 2015
Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Source: Eur Respir J 2007; 29: 117-126 Year: 2007
Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan Source: Eur Respir J 2006; 28: Suppl. 50, 151s Year: 2006
Genotyping single-nucleotide polymorphisms (SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR-1 and CCND-1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC) Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007
Combined cytotoxic treatment (methotrexate and cyclophosphamide) in association with prednisone in sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 713s Year: 2004
Effect of MTHFR C677T polymorphism on allergic airway disease in asthma patients Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics Year: 2018